Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
uracanqing
- Development stage
- Unknown
- Lead developer
- Yunnan Provincial Hospital of Traditional Chinese Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Uracanqing is a Traditional Chinese Medicine (TCM) hospital preparation developed by The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine for the treatment of gout and hyperuricemia. Formulated as granules, it is composed of several herbal ingredients known in TCM for their ability to clear heat, resolve dampness, and activate blood circulation. The preparation works by lowering serum uric acid levels through the inhibition of uric acid production and the promotion of its renal excretion. It also exhibits anti-inflammatory and analgesic properties, making it effective for managing both acute gouty arthritis attacks and chronic hyperuricemia. As a hospital-made preparation (院内制剂), it is approved for clinical use within the developing institution and is a staple of their rheumatology department.
- Brand names
- Uracanqing
- Other names
- Uracanqing GranulesYousuanqing Keli优酸清颗粒
02
Targets
URAT1 (Uric Acid Transporter 1)XO (Xanthine Oxidoreductase)
Beyond the preview
Go deeper on uracanqing.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on uracanqing.